RESUMEN
OBJECTIVE: To compare risk scores computed by DxCG (Verisk) and Centers for Medicare and Medicaid Services (CMS) V21. RESEARCH DESIGN: Analysis of administrative data from the Department of Veterans Affairs (VA) for fiscal years 2010 and 2011. STUDY DESIGN: We regressed total annual VA costs on predicted risk scores. Model fit was judged by R-squared, root mean squared error, mean absolute error, and Hosmer-Lemeshow goodness-of-fit tests. Recalibrated models were tested using split samples with pharmacy data. DATA COLLECTION: We created six analytical files: a random sample (n = 2 million), high cost users (n = 261,487), users over age 75 (n = 644,524), mental health and substance use users (n = 830,832), multimorbid users (n = 817,951), and low-risk users (n = 78,032). PRINCIPAL FINDINGS: The DxCG Medicaid with pharmacy risk score yielded substantial gains in fit over the V21 model. Recalibrating the V21 model using VA pharmacy data-generated risk scores with similar fit statistics to the DxCG risk scores. CONCLUSIONS: Although the CMS V21 and DxCG prospective risk scores were similar, the DxCG model with pharmacy data offered improved fit over V21. However, health care systems, such as the VA, can recalibrate the V21 model with additional variables to develop a tailored risk score that compares favorably to the DxCG models.
Asunto(s)
Centers for Medicare and Medicaid Services, U.S. , Costos de la Atención en Salud , Ajuste de Riesgo/métodos , United States Department of Veterans Affairs , Reclamos Administrativos en el Cuidado de la Salud/economía , Sistemas de Información en Farmacia Clínica , Humanos , Modelos Econométricos , Estudios Prospectivos , Estados UnidosRESUMEN
BACKGROUND AND OBJECTIVE: How patients respond to being notified of a large-scale adverse event (LSAE), such as improper sterilisation of medical equipment that exposes them to bloodborne pathogens, is not well known. The objective of this study was to determine, using administrative data, the intended and unintended consequences of patient notification following a LSAE. METHODS: We examined five LSAEs where patients may have been inadvertently exposed to hepatitis C virus (HCV), HIV, and hepatitis B virus (HBV). A total of 9638 cases were identified at five Department of Veteran Affairs (VA) medical facilities between 2009 and 2012. We identified controls at the same facility prior to the exposure period and at neighbouring facilities (n=45,274). Difference-in-differences models were used with Veterans Health Administration (VHA) and Medicare data to examine infectious disease testing rates and subsequent utilisation patterns. RESULTS: Receipt of a LSAE notification was associated with a 73.2, 76.8 and 77.1 adjusted percentage point increase for HCV, HIV and HBV testing, respectively (all p<0.001). Compared with white patients, African-American patients were significantly less likely to return to VHA for follow-up testing. Patients exposed to a dental LSAE reduced their use of preventive and restorative dental care over the subsequent year, but they eventually came back to VHA for dental services 18-months post exposure. CONCLUSIONS: The majority of patients notified of a LSAE responded by getting tested for HCV, HIV and HBV, although there remains room for improvement. Potential exposure to a LSAE was associated with increased odds of subsequently using non-VA facilities, but the size and timing of the shift depended on the type of care.
Asunto(s)
Negro o Afroamericano/psicología , Trazado de Contacto/estadística & datos numéricos , Revelación/estadística & datos numéricos , Virosis/diagnóstico , Virosis/transmisión , Población Blanca/psicología , Adulto , Anciano , Femenino , Infecciones por VIH/diagnóstico , Infecciones por VIH/transmisión , Hepatitis B/diagnóstico , Hepatitis B/transmisión , Hepatitis C/diagnóstico , Hepatitis C/transmisión , Humanos , Masculino , Persona de Mediana Edad , Estados Unidos , United States Department of Veterans Affairs/estadística & datos numéricosAsunto(s)
Antifúngicos/uso terapéutico , Conidiobolus , Enfermedades de los Perros/tratamiento farmacológico , Itraconazol/uso terapéutico , Neumonía/veterinaria , Cigomicosis/veterinaria , Animales , Conidiobolus/efectos de los fármacos , Perros , Huésped Inmunocomprometido , Masculino , Neumonía/tratamiento farmacológico , Resultado del Tratamiento , Cigomicosis/tratamiento farmacológicoAsunto(s)
Enfermedades de los Perros/diagnóstico , Cadenas Ligeras de Inmunoglobulina/análisis , Mieloma Múltiple/veterinaria , Escápula , Animales , Examen de la Médula Ósea/veterinaria , Diagnóstico Diferencial , Enfermedades de los Perros/sangre , Enfermedades de los Perros/diagnóstico por imagen , Enfermedades de los Perros/inmunología , Enfermedades de los Perros/patología , Perros , Femenino , Miembro Anterior , Cojera Animal/etiología , Mieloma Múltiple/complicaciones , Mieloma Múltiple/diagnóstico , Radiografía , CintigrafíaRESUMEN
Reticulocytes are anucleate immature red blood cells that contain a network of RNA, organelles, and mitochondria, which stain with supravital dyes. Both aggregate and punctate reticulocytes are present in domestic cats, and aggregate reticulocytes are used to assess the degree of regeneration in anemic dogs and cats. Multiple factors influence the degree of regenerative response to anemia. These factors include time of reticulocyte measurement, concurrent diseases, species, and ongoing therapy. Although many automated systems for reticulocyte enumeration exist, manual counts remain the gold standard in veterinary medicine.
Asunto(s)
Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Perros/sangre , Enfermedades de los Perros/diagnóstico , Enfermedades Hematológicas/veterinaria , Recuento de Reticulocitos/veterinaria , Animales , Gatos , Diagnóstico Diferencial , Perros , Femenino , Enfermedades Hematológicas/sangre , Enfermedades Hematológicas/diagnóstico , MasculinoRESUMEN
A 12-year-old neutered male Shar-Pei was presented to the North Carolina State University Veterinary Teaching Hospital cardiology service with a 2-week history of coughing and a 2-day history of lethargy and anorexia. Pleural effusion and a mediastinal mass were detected with thoracic radiographs. Ten mL of fluid were removed via thoracocentesis, and cytologic examination of the fluid revealed marked eosinophilic inflammation and few atypical mast cells. Mast cell neoplasia was suspected. Aspirates of the mediastinal mass, abdominal lymph nodes, and bone marrow contained similar pleomorphic mast cells and increased numbers of eosinophils. The dog was diagnosed with systemic (visceral) mastocytosis, a rare form of neoplasia in dogs, and was euthanized. These tumors carry a poor to grave prognosis and the etiology is uncertain.